Westfield Capital Management CO LP Vaxcyte, Inc. Transaction History
Westfield Capital Management CO LP
- $21.2 Billion
- Q3 2024
A detailed history of Westfield Capital Management CO LP transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 1,739,874 shares of PCVX stock, worth $154 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
1,739,874
Previous 1,929,348
9.82%
Holding current value
$154 Million
Previous $146 Million
36.35%
% of portfolio
0.94%
Previous 0.73%
Shares
5 transactions
Others Institutions Holding PCVX
# of Institutions
357Shares Held
123MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.01 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$968 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$881 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$770 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$434 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.26B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...